These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30030794)

  • 1. The Molecular Biology of HIV Latency.
    Khoury G; Darcis G; Lee MY; Bouchat S; Van Driessche B; Purcell DFJ; Van Lint C
    Adv Exp Med Biol; 2018; 1075():187-212. PubMed ID: 30030794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying mechanisms of HIV-1 latency.
    Romani B; Allahbakhshi E
    Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
    Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
    Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multifaceted Contributions of Chromatin to HIV-1 Integration, Transcription, and Latency.
    De Crignis E; Mahmoudi T
    Int Rev Cell Mol Biol; 2017; 328():197-252. PubMed ID: 28069134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Basis for Human Immunodeficiency Virus Latency.
    Mbonye U; Karn J
    Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Transcription Inhibitors Increase the Synthesis of Viral Non-Coding RNA that Contribute to Latency.
    Akpamagbo YA; DeMarino C; Pleet ML; Schwab A; Rodriguez M; Barclay RA; Sampey G; Iordanskiy S; El-Hage N; Kashanchi F
    Curr Pharm Des; 2017; 23(28):4133-4144. PubMed ID: 28641535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relevance of Post-Transcriptional Mechanisms in HIV Latency Reversal.
    Sarracino A; Marcello A
    Curr Pharm Des; 2017; 23(28):4103-4111. PubMed ID: 28782474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transcription inhibition and generation of suppressive viral non-coding RNAs.
    Pinto DO; Scott TA; DeMarino C; Pleet ML; Vo TT; Saifuddin M; Kovalskyy D; Erickson J; Cowen M; Barclay RA; Zeng C; Weinberg MS; Kashanchi F
    Retrovirology; 2019 Apr; 16(1):13. PubMed ID: 31036006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latency: the hidden HIV-1 challenge.
    Marcello A
    Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin.
    Mujtaba S; Zhou MM
    Methods; 2011 Jan; 53(1):97-101. PubMed ID: 20828615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multifactorial nature of HIV-1 latency.
    Lassen K; Han Y; Zhou Y; Siliciano J; Siliciano RF
    Trends Mol Med; 2004 Nov; 10(11):525-31. PubMed ID: 15519278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.
    Mbonye U; Karn J
    Virology; 2014 Apr; 454-455():328-39. PubMed ID: 24565118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
    Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
    EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing.
    Khoury G; Purcell DFJ
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure.
    Mori L; Valente ST
    Viruses; 2020 May; 12(5):. PubMed ID: 32403278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription.
    Hayashi T; Jean M; Huang H; Simpson S; Santoso NG; Zhu J
    Antiviral Res; 2017 Oct; 146():76-85. PubMed ID: 28842263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.